Our study presents the tumor suppressor characteristics of TAGLN in bladder cancer, both in vitro and in vivo, and agrees with the concept of that the role of transgelin-2 in tumor development might be contradictory to the role of TAGLN [27]. The gene discussed is TAGLN2; the disease is urinary bladder carcinoma.